Picture of Delivra Health Brands logo

DHB Delivra Health Brands Income Statement

0.000.00%
ca flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapNeutral

Annual income statement for Delivra Health Brands, fiscal year end - June 30th, CAD millions except per share, conversion factor applied.

R2019
June 30th
R2020
June 30th
2021
June 30th
2022
June 30th
2023
June 30th
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue5.987.787.968.149.79
Cost of Revenue
Gross Profit2.021.522.913.385.22
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses32.36529.814.310.3
Operating Profit-26.3-57.2-21.9-6.18-0.467
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Net Income Before Taxes-26.2-58.7-22.7-7.01-0.184
Net Income After Taxes-26.2-58.7-22.7-7.01-0.184
Minority Interest
Net Income Before Extraordinary Items
Extraordinary Items
Net Income-27.9-79.9-28.5-7.01-0.184
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income-27.9-79.9-28.5-7.01-0.184
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS-0.1-0.067-0.039-0.021-0.005